Why do people with ehlers danlos look young

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: People with Ehlers-Danlos syndromes (EDS) often appear younger than their chronological age due to specific genetic mutations affecting collagen production. The hypermobile type (hEDS), which accounts for approximately 80-90% of EDS cases, frequently presents with unusually smooth, velvety skin that resists wrinkling. Research indicates this youthful appearance results from abnormal collagen fibrils that provide excessive skin elasticity, with studies showing EDS patients' skin can stretch 1.5-2 times more than typical skin. This collagen defect, present from birth, creates a persistent youthful appearance that doesn't correlate with actual aging processes.

Key Facts

Overview

Ehlers-Danlos syndromes (EDS) represent a group of 13 inherited connective tissue disorders first systematically described in the early 20th century. French dermatologist Henri-Alexandre Danlos published his observations in 1908, building upon earlier work by Danish dermatologist Edvard Ehlers who documented cases in 1901. These disorders affect approximately 1 in 5,000 individuals globally, though prevalence estimates vary by type. The conditions are characterized by genetic defects in collagen production or processing, with collagen being the most abundant protein in the human body, comprising about 25-35% of total protein content. EDS manifests across multiple body systems, with the hypermobile type (hEDS) being most common at 80-90% of cases, followed by classical type (cEDS) at 5-10%. Diagnosis typically involves clinical evaluation using the 2017 International Classification criteria, with genetic testing available for some types. The conditions affect people of all ethnicities and genders equally, though some types show inheritance patterns.

How It Works

The youthful appearance in Ehlers-Danlos syndromes stems from fundamental defects in collagen structure and function. Collagen, which constitutes approximately 70-80% of the dry weight of skin, provides structural support and elasticity. In EDS, genetic mutations disrupt collagen synthesis, assembly, or processing. For classical EDS, mutations occur in COL5A1 or COL5A2 genes encoding type V collagen, while vascular EDS involves COL3A1 gene mutations affecting type III collagen. These defects create abnormal collagen fibrils that are thinner, more irregular, and less organized than normal collagen. The resulting skin has increased elasticity, often stretching 1.5-2 times beyond typical limits, and exhibits a characteristic velvety texture. This hyperelasticity prevents normal wrinkle formation as collagen fibers fail to provide adequate resistance to repetitive facial movements. Additionally, reduced collagen cross-linking decreases skin stiffness, while abnormal elastin distribution further contributes to the youthful appearance. The collagen abnormalities are present from embryonic development onward, creating a persistent effect that doesn't diminish with chronological aging.

Why It Matters

The youthful appearance in EDS has significant real-world implications beyond cosmetic concerns. This characteristic serves as an important diagnostic clue, with the velvety, hyperextensible skin being one of the major diagnostic criteria for classical EDS. However, this seemingly positive trait accompanies serious health consequences, including joint hypermobility affecting 90% of patients, chronic pain in 75-85% of cases, and increased risk of arterial rupture in vascular EDS with median survival of 48 years. The disconnect between youthful appearance and actual health status can lead to medical professionals underestimating patients' symptoms and disability. Furthermore, research into EDS collagen defects has advanced understanding of connective tissue biology, contributing to developments in wound healing and tissue engineering. Recognizing EDS early allows for appropriate management of associated conditions like autonomic dysfunction affecting 60-70% of patients and gastrointestinal issues in 50-80% of cases.

Sources

  1. Ehlers-Danlos syndromesCC-BY-SA-4.0
  2. The Ehlers-Danlos SocietyEducational use
  3. GeneReviews: Ehlers-Danlos SyndromesPublic domain

Missing an answer?

Suggest a question and we'll generate an answer for it.